Y-BOX BINDING PROTEIN-1 ACTIVATION MAY MODIFY THE RESPONSES TO ENDOCRINE AND HER2-TARGETED THERAPEUTICS IN BREAST CANCER

被引：0
|
作者：
Kuwano, Michihiko [1 ]
Shibata, Tomohiro [2 ]
Kawahara, Akihiko [3 ]
Hattori, Satoshi [4 ]
Takahashi, Ryuji [5 ]
Watari, Kosuke [2 ]
Murakami, Yuichi [2 ]
Izumi, Hiroto [6 ]
Kage, Masayoshi [3 ]
Ono, Mayumi [2 ]
机构：
[1] Kyushu Univ, Lab Mol Canc Biol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan
[2] Kyushu Univ, Dept Pharmaceut Oncol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan
[3] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan
[4] Kurume Univ, Ctr Biostat, Kurume, Fukuoka, Japan
[5] Kyushu Med Ctr, Dept Breast Care Ctr, Fukuoka, Japan
[6] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu435.89
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2-15-2
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Y-BOX BINDING PROTEIN-1 PROMOTES CASTRATION-RESISTANT PROSTATE CANCER GROWTH VIA ANDROGEN RECEPTOR EXPRESSION
    Shiota, Masaki
    Takeuchi, Ario
    Song, YooHyun
    Yokomizo, Akira
    Kashiwagi, Eiji
    Uchiumi, Takeshi
    Kuroiwa, Kentaro
    Tatsugami, Katsunori
    Fujimoto, Naohiro
    Oda, Yoshinao
    Naito, Seiji
    JOURNAL OF UROLOGY, 2013, 189 (04): : E85 - E86
  • [42] The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells
    J Dhillon
    A Astanehe
    C Lee
    A Fotovati
    K Hu
    S E Dunn
    Oncogene, 2010, 29 : 6294 - 6300
  • [43] The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells
    Dhillon, J.
    Astanehe, A.
    Lee, C.
    Fotovati, A.
    Hu, K.
    Dunn, S. E.
    ONCOGENE, 2010, 29 (47) : 6294 - 6300
  • [44] Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to a adjuvant chemotherapy in breast cancer
    Huang, JX
    Tan, PH
    Li, KB
    Matsumoto, K
    Tsujimoto, M
    Bay, BH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (03) : 607 - 613
  • [45] The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
    Stope, M. B.
    Weiss, M.
    Popp, S. L.
    Joffroy, C.
    Buck, M. B.
    Mustea, A.
    Brucker, S.
    Wallwiener, D.
    Knabbe, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 16 - 18
  • [46] Y-Box binding protein 1 expression in breast cancer and its correlation with hormone receptors and other prognostic markers
    Bansal, Taruna
    Tanveer, Nadeem
    Singh, Usha Rani
    Sharma, Sonal
    Kaur, Navneet
    JOURNAL OF LABORATORY PHYSICIANS, 2018, 10 (04) : 420 - 425
  • [47] Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1)
    Zeng, San
    Xiong, May P.
    BIOMATERIALS, 2013, 34 (28) : 6882 - 6892
  • [48] Tumours have a sex-relevance to the multifunctional oncoprotein Y-box binding protein-1 (YB-1)
    Croghan, S.
    Rohan, P.
    Manecksha, R. P.
    Lynch, T. H.
    Marignol, L.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1236 - S1237
  • [49] FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer
    Imada, Kenjiro
    Shiota, Masaki
    Kuroiwa, Kentaro
    Sugimoto, Masaaki
    Abe, Tatsuro
    Kohashi, Kenichi
    Yokomizo, Akira
    Eto, Masatoshi
    Naito, Seiji
    Oda, Yoshinao
    PROSTATE, 2017, 77 (02): : 145 - 153
  • [50] Y-box binding protein 1 (YB-1) and Akt activation in expression of malignancy-related genes in ovarian cancer
    Basaki, Yuji
    Hosoi, Fumihito
    Oda, Yoshinao
    Fotovati, Abbas
    Sakai, Kazuko
    Shimoyama, Tatsu
    Nishio, Kazuto
    Ono, Mayumi
    Kuwano, Michihiko
    CANCER RESEARCH, 2006, 66 (08)
12345